Strategic Investments in the EU and US strengthen Vetter’s Global Footprint Vetter, one of the world’s leading pharmaceutical service providers for the production of injectable...
Today, Novartis, a leading global innovative medicines company, announced a planned $23 billion investment over 5 years in US-based infrastructure, ensuring all key Novartis medicines for US...
President Mung Chiang joins industry leaders during SXSW to discuss the university’s role in shaping the future of pharma Purdue University’s position as a key...